These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14643458)

  • 1. What the rodent prefrontal cortex can teach us about attention-deficit/hyperactivity disorder: the critical role of early developmental events on prefrontal function.
    Sullivan RM; Brake WG
    Behav Brain Res; 2003 Nov; 146(1-2):43-55. PubMed ID: 14643458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.
    Arnsten AF
    CNS Drugs; 2009; 23 Suppl 1():33-41. PubMed ID: 19621976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum.
    Ruocco LA; Treno C; Gironi Carnevale UA; Arra C; Mattern C; Huston JP; de Souza Silva MA; Nikolaus S; Scorziello A; Nieddu M; Boatto G; Illiano P; Pagano C; Tino A; Sadile AG
    Amino Acids; 2014 Sep; 46(9):2105-22. PubMed ID: 24862315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder.
    Viggiano D; Ruocco LA; Arcieri S; Sadile AG
    Neural Plast; 2004; 11(1-2):133-49. PubMed ID: 15303310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
    Arnsten AF
    J Clin Psychiatry; 2006; 67 Suppl 8():7-12. PubMed ID: 16961424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function.
    Brennan AR; Arnsten AF
    Ann N Y Acad Sci; 2008; 1129():236-45. PubMed ID: 18591484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].
    Emond V; Joyal C; Poissant H
    Encephale; 2009 Apr; 35(2):107-14. PubMed ID: 19393378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemispheric asymmetry in stress processing in rat prefrontal cortex and the role of mesocortical dopamine.
    Sullivan RM
    Stress; 2004 Jun; 7(2):131-43. PubMed ID: 15512858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug policy and treatment bias due to the dopamine-deficit theory of child attention-deficit hyperactivity disorder.
    Rastmanesh R
    Atten Defic Hyperact Disord; 2010 Nov; 2(3):149-57. PubMed ID: 21432601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural, pharmacological, morpho-functional molecular studies reveal a hyperfunctioning mesocortical dopamine system in an animal model of attention deficit and hyperactivity disorder.
    Viggiano D; Vallone D; Ruocco LA; Sadile AG
    Neurosci Biobehav Rev; 2003 Nov; 27(7):683-9. PubMed ID: 14624812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
    Russell VA
    Behav Brain Res; 2002 Mar; 130(1-2):191-6. PubMed ID: 11864734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?].
    Villemonteix T; Purper-Ouakil D; Romo L
    Encephale; 2015 Apr; 41(2):108-14. PubMed ID: 24703785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the role of the prefrontal cortex in the pathophysiology of attention-deficit/hyperactivity disorder.
    Halperin JM; Schulz KP
    Psychol Bull; 2006 Jul; 132(4):560-81. PubMed ID: 16822167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression of synaptosomal-associated protein 25 (SNAP-25) in the prefrontal cortex of the spontaneously hypertensive rat (SHR).
    Li Q; Wong JH; Lu G; Antonio GE; Yeung DK; Ng TB; Forster LE; Yew DT
    Biochim Biophys Acta; 2009 Aug; 1792(8):766-76. PubMed ID: 19482079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
    Russell V; de Villiers A; Sagvolden T; Lamm M; Taljaard J
    Brain Res; 1995 Apr; 676(2):343-51. PubMed ID: 7614004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shared and disorder-specific prefrontal abnormalities in boys with pure attention-deficit/hyperactivity disorder compared to boys with pure CD during interference inhibition and attention allocation.
    Rubia K; Halari R; Smith AB; Mohammad M; Scott S; Brammer MJ
    J Child Psychol Psychiatry; 2009 Jun; 50(6):669-78. PubMed ID: 19236528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early stress and chronic methylphenidate cross-sensitize dopaminergic responses in the adolescent medial prefrontal cortex and nucleus accumbens.
    Jezierski G; Zehle S; Bock J; Braun K; Gruss M
    J Neurochem; 2007 Dec; 103(6):2234-44. PubMed ID: 17924950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey.
    Kodama T; Kojima T; Honda Y; Hosokawa T; Tsutsui KI; Watanabe M
    J Neurosci; 2017 Mar; 37(9):2387-2394. PubMed ID: 28154152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
    Bymaster FP; Katner JS; Nelson DL; Hemrick-Luecke SK; Threlkeld PG; Heiligenstein JH; Morin SM; Gehlert DR; Perry KW
    Neuropsychopharmacology; 2002 Nov; 27(5):699-711. PubMed ID: 12431845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.